comparemela.com

Latest Breaking News On - Non alcoholic fatty liver disease - Page 11 : comparemela.com

VGI Health Technology Limited (NSX:VTL) HREC Approval for Phase II Clinical Study

VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II clinical study in Pancreatic Cancer.

£30M clinical study will enhance the understanding of NASH cirrhosis

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.